Response to Comments: Platelet Rich Plasma Injections for Non-Wound Injections

This document A58894 is a response-to-comments notice regarding proposed LCD L39023 (Platelet-Rich Plasma Injections for Non-Wound Injections). It summarizes the comment and notice periods and states the LCD effective date (January 3, 2022), but does not itself specify coverage indications, limitations, documentation requirements, or frequency limits; refer to LCD L39023 for the detailed coverage criteria.

"No specific clinical indications for platelet-rich plasma (PRP) non-wound injections are provided in this response document; refer to LCD L39023 for detailed coverage criteria."

Sign up to see full coverage criteria, indications, and limitations.